You have free access to this content

Alimentary Pharmacology & Therapeutics

Cover image for Vol. 21 Issue 9

May 2005

Volume 21, Issue 9

Pages 1055–1178

  1. Systematic Review and Meta-Analysis

    1. Top of page
    2. Systematic Review and Meta-Analysis
    3. Original Articles
    1. You have free access to this content
  2. Original Articles

    1. Top of page
    2. Systematic Review and Meta-Analysis
    3. Original Articles
    1. You have free access to this content
      Infliximab reverses growth hormone resistance associated with inflammatory bowel disease (pages 1063–1071)

      U. Vespasiani Gentilucci, R. Caviglia, A. Picardi, S. Carotti, M. Ribolsi, G. Galati, T. Petitti, A. Afeltra and M. Cicala

      Version of Record online: 22 APR 2005 | DOI: 10.1111/j.1365-2036.2005.02449.x

    2. You have free access to this content
      Seasonality of vitamin D status and bone turnover in patients with Crohn's disease (pages 1073–1083)

      D. McCarthy, P. Duggan, M. O'Brien, M. Kiely, J. McCarthy, F. Shanahan and K. D. Cashman

      Version of Record online: 22 APR 2005 | DOI: 10.1111/j.1365-2036.2005.02446.x

    3. You have free access to this content
      The significance of rectal bleeding after pelvic radiotherapy (pages 1085–1090)

      H. R. T. Williams, P. Vlavianos, P. Blake, D. P. Dearnaley, D. Tait and H. J. N. Andreyev

      Version of Record online: 22 APR 2005 | DOI: 10.1111/j.1365-2036.2005.02438.x

    4. You have free access to this content
      Inflammatory gene signature in ulcerative colitis with cDNA macroarray analysis (pages 1091–1097)

      S. Okahara, Y. Arimura, T. Yabana, K. Kobayashi, A. Gotoh, S. Motoya, A. Imamura, T. Endo and K. Imai

      Version of Record online: 22 APR 2005 | DOI: 10.1111/j.1365-2036.2005.02443.x

    5. You have free access to this content
      Multicentre randomized-controlled clinical trial of Ipocol, a new enteric-coated form of mesalazine, in comparison with Asacol in the treatment of ulcerative colitis (pages 1099–1104)

      A. Forbes, A. Al-Damluji, S. Ashworth, M. Bramble, K. Herbert, J. Ho, J.-Y. Kang, R. Przemioslo and A. Shetty

      Version of Record online: 22 APR 2005 | DOI: 10.1111/j.1365-2036.2005.02442.x

    6. You have free access to this content
    7. You have free access to this content
      Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study (pages 1111–1119)

      O. A. Paoluzi, F. Iacopini, R. Pica, P. Crispino, A. Marcheggiano, A. Consolazio, M. Rivera and P. Paoluzi

      Version of Record online: 22 APR 2005 | DOI: 10.1111/j.1365-2036.2005.02458.x

    8. You have free access to this content
      Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan (pages 1121–1126)

      T. Kamada, J. Hata, K. Sugiu, H. Kusunoki, M. Ito, S. Tanaka, K. Inoue, Y. Kawamura, K. Chayama and K. Haruma

      Version of Record online: 22 APR 2005 | DOI: 10.1111/j.1365-2036.2005.02459.x

    9. You have free access to this content
      Symptoms of gastro-oesophageal reflux disease and the severity of obstructive sleep apnoea syndrome are not related in sleep disorders center patients (pages 1127–1133)

      H.-N. Kim, R. D. Vorona, M. P. Winn, M. Doviak, D. A. Johnson and J. Catesby Ware

      Version of Record online: 22 APR 2005 | DOI: 10.1111/j.1365-2036.2005.02447.x

    10. You have free access to this content
      Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales (pages 1135–1143)

      J. M. Mason, B. Delaney, P. Moayyedi, M. Thomas, R. Walt and The North of England Dyspepsia Guideline Development Group

      Version of Record online: 22 APR 2005 | DOI: 10.1111/j.1365-2036.2005.02445.x

    11. You have free access to this content
      Effect of different organic acids (citric, malic and ascorbic) on intragastric urease activity (pages 1145–1148)

      A. Agha, A. R. Opekun, S. Abudayyeh and D. Y. Graham

      Version of Record online: 22 APR 2005 | DOI: 10.1111/j.1365-2036.2005.02440.x

    12. You have free access to this content
    13. You have free access to this content
      Predicting which patients can resume oral nutrition after percutaneous endoscopic gastrostomy tube placement (pages 1155–1161)

      A. D. Naik, N. S. Abraham, V. M. L. Roche and J. Concato

      Version of Record online: 22 APR 2005 | DOI: 10.1111/j.1365-2036.2005.02464.x

    14. You have free access to this content
      The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation (pages 1163–1171)

      M. van Zonneveld, H. J. Flink, E. Verhey, H. Senturk, S. Zeuzem, U. S. Akarca, Y. Cakaloglu, C. Simon, T. M. K. So, G. Gerken, R. A. de Man, B. E. Hansen, S. W. Schalm, H. L. A. Janssen and The HBV 99-01 Study Group

      Version of Record online: 22 APR 2005 | DOI: 10.1111/j.1365-2036.2005.02453.x

    15. You have free access to this content
      Impact of liver steatosis on virological response in elderly Italian patients with chronic hepatitis C treated with peg-interferon alpha-2b plus ribavarin (pages 1173–1178)

      P. Fabris, A. Floreani, A. Carlotto, V. Baldo, L. Bozzola, M. T. Giordani, F. Negro, M. Rassu, A. Tramarin and F. de Lalla

      Version of Record online: 22 APR 2005 | DOI: 10.1111/j.1365-2036.2005.02452.x

SEARCH

SEARCH BY CITATION